{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:18:01Z","timestamp":1762377481724},"reference-count":23,"publisher":"The Japanese Society of Nuclear Cardiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.17996\/anc.23-00002","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T22:18:14Z","timestamp":1698704294000},"page":"61-67","source":"Crossref","is-referenced-by-count":4,"title":["Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac &lt;sup&gt;123&lt;\/sup&gt;I-metaiodobenzylguanidine Sympathetic Imaging Using SPECT\/CT"],"prefix":"10.17996","volume":"9","author":[{"given":"Shintaro","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Functional Imaging and Artificial Intelligence, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shibutani","sequence":"additional","affiliation":[{"name":"Department of Quantum Medical Technology, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Yoneyama","sequence":"additional","affiliation":[{"name":"Department of Radiological Technology, Kanazawa University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Radiological Technology, Kanazawa University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Kinuya","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7364","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Verschure DO, Nakajima K, Verberne HJ. Cardiac <sup>123<\/sup>I-<i>m<\/i>IBG imaging in heart failure. Pharmaceuticals (Basel) 2022; 15: 656.","DOI":"10.3390\/ph15060656"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Verschure DO, Bongers V, Hagen PJ, Somsen GA, van Eck-Smit BLF, Verberne HJ. Impact of a predefined mediastinal ROI on inter-observer variability of planar <sup>123<\/sup>I-MIBG heart-to-mediastinum ratio. J Nucl Cardiol 2014; 21: 605&ndash;13.","DOI":"10.1007\/s12350-014-9854-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pellegrino T, Petretta M, De Luca S, et al. Observer reproducibility of results from a low-dose <sup>123<\/sup>I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure. Eur J Nucl Med Mol Imaging 2013; 40: 1549&ndash;57.","DOI":"10.1007\/s00259-013-2461-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bateman TM, Ananthasubramaniam K, Berman DS, et al. Reliability of the <sup>123<\/sup>I-mIBG heart\/mediastinum ratio: Results of a multicenter test-retest reproducibility study. J Nucl Cardiol 2019; 26: 1555&ndash;65.","DOI":"10.1007\/s12350-017-1183-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakajima K, Nakata T, Doi T, et al. Validation of 2-year <sup>123<\/sup>I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure. Eur Heart J Cardiovasc Imaging 2018; 19: 749&ndash;56.","DOI":"10.1093\/ehjci\/jey016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakata T, Nakajima K, Yamashina S, et al. A pooled analysis of multicenter cohort studies of <sup>123<\/sup>I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013; 6: 772&ndash;84.","DOI":"10.1016\/j.jcmg.2013.02.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Travin MI, Henzlova MJ, van Eck-Smit BLF, et al. Assessment of <sup>123<\/sup>I-mIBG and <sup>99m<\/sup>Tc-tetrofosmin single-photon emission computed tomographic images for the prediction of arrhythmic events in patients with ischemic heart failure: Intermediate severity innervation defects are associated with higher arrhythmic risk. J Nucl Cardiol 2017; 24: 377&ndash;91.","DOI":"10.1007\/s12350-015-0336-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nakajima K, Nakata T, Doi T, Tada H, Maruyama K. Machine learning-based risk model using <sup>123<\/sup>I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failure. J Nucl Cardiol 2022; 29: 190&ndash;201.","DOI":"10.1007\/s12350-020-02173-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakajima K, Nakata T, Yamada T, et al. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using <sup>123<\/sup>I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging 2014; 41: 1673&ndash;82.","DOI":"10.1007\/s00259-014-2759-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Orimo S, Suzuki M, Inaba A, Mizusawa H. <sup>123<\/sup>I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: A systematic review and meta-analysis. Parkinsonism Relat Disord 2012; 18: 494&ndash;500.","DOI":"10.1016\/j.parkreldis.2012.01.009"},{"key":"11","unstructured":"11. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017; 89: 88&ndash;100."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamada M, Komatsu J, Nakamura K, et al. Diagnostic criteria for dementia with lewy bodies: Updates and future directions. J Mov Disord 2020; 13: 1&ndash;10.","DOI":"10.14802\/jmd.19052"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakajima K, Yamada M. <sup>123<\/sup>I-meta-iodobenzylguanidine sympathetic imaging: Standardization and application to neurological diseases. Chonnam Med J 2016; 52: 145&ndash;50.","DOI":"10.4068\/cmj.2016.52.3.145"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Klene C, Jungen C, Okuda K, et al. Influence of ROI definition on the heart-to-mediastinum ratio in planar <sup>123<\/sup>I-MIBG imaging. J Nucl Cardiol 2018; 25: 208&ndash;16.","DOI":"10.1007\/s12350-016-0708-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okuda K, Nakajima K, Hosoya T, et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol 2011; 18: 82&ndash;9.","DOI":"10.1007\/s12350-010-9313-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tilkemeier PL, Bourque J, Doukky R, Sanghani R, Weinberg RL. ASNC imaging guidelines for nuclear cardiology procedures: Standardized reporting of nuclear cardiology procedures. J Nucl Cardiol 2017; 24: 2064&ndash;128.","DOI":"10.1007\/s12350-017-1057-y"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Soman P, Travin MI, Gerson M, Cullom SJ, Thompson R. I-123 MIBG cardiac imaging. J Nucl Cardiol 2015; 22: 677&ndash;85.","DOI":"10.1007\/s12350-015-0108-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Flotats A, Carri&oacute; I, Agostini D, et al. Proposal for standardization of <sup>123<\/sup>I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010; 37: 1802&ndash;12.","DOI":"10.1007\/s00259-010-1491-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol 2006; 13: 251&ndash;60.","DOI":"10.1007\/BF02971250"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Dickson JC, Armstrong IS, Gabi&ntilde;a PM, et al. EANM practice guideline for quantitative SPECT-CT. Eur J Nucl Med Mol Imaging 2023; 50: 980&ndash;95.","DOI":"10.1007\/s00259-022-06028-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakajima K, Okuda K, Matsuo S, Wakabayashi H, Kinuya S. Is <sup>123<\/sup>I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database. Ann Nucl Med 2018; 32: 175&ndash;81.","DOI":"10.1007\/s12149-018-1231-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nakajima K, Scholte AJHA, Nakata T, et al. Cardiac sympathetic nervous system imaging with <sup>123<\/sup>I-meta-iodobenzylguanidine: Perspectives from Japan and Europe. J Nucl Cardiol 2017; 24: 952&ndash;60.","DOI":"10.1007\/s12350-017-0818-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Saito S, Nakajima K, Edenbrandt L, Enqvist O, Ul&eacute;n J, Kinuya S. Convolutional neural network-based automatic heart segmentation and quantitation in <sup>123<\/sup>I-metaiodobenzylguanidine SPECT imaging. EJNMMI Res 2021; 11: 105.","DOI":"10.1186\/s13550-021-00847-x"}],"container-title":["Annals of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/9\/1\/9_23-00002\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T04:05:59Z","timestamp":1699070759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/9\/1\/9_23-00002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.17996\/anc.23-00002","relation":{},"ISSN":["2189-3926","2424-1741"],"issn-type":[{"value":"2189-3926","type":"print"},{"value":"2424-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"23-00002"}}